Epizyme Inc (EPZM) Insider Trading
- $81,308,409.37
- $44,581,576.74
- April 11, 2022
- Robert A Copeland
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 9, 2016 | CFO | 1,013 | $10.40 | Sell | $10,535.20 | |
Oct. 10, 2016 | CFO | 1,013 | $9.72 | Sell | $9,846.36 | |
Sept. 9, 2016 | CFO | 1,013 | $7.55 | Sell | $7,648.15 | |
Aug. 9, 2016 | CFO | 1,013 | $9.05 | Sell | $9,167.65 | |
Aug. 1, 2016 | Insider | 4,000 | $10.37 | Sell | $41,480.00 | |
July 11, 2016 | CFO | 1,013 | $10.36 | Sell | $10,494.68 | |
July 5, 2016 | Insider | 4,000 | $10.03 | Sell | $40,120.00 | |
June 9, 2016 | CFO | 1,013 | $12.49 | Sell | $12,652.37 | |
April 12, 2016 | CFO | 1,013 | $12.42 | Sell | $12,581.46 | |
March 9, 2016 | CFO | 1,006 | $9.33 | Sell | $9,385.98 | |
Feb. 29, 2016 | Insider | 636 | $7.47 | Buy | $4,750.92 | |
Feb. 10, 2016 | CFO | 12,158 | $9.54 | Sell | $115,987.32 | |
Jan. 12, 2016 | Major Shareholder | 555,555 | $9.00 | Buy | $4,999,995.00 | |
Jan. 12, 2016 | Director | 1,111,111 | $9.00 | Buy | $9,999,999.00 | |
Jan. 4, 2016 | insider | 4,185 | $15.58 | Sell | $65,202.30 | |
Dec. 30, 2015 | Director | 32,108 | $18.01 | Sell | $578,265.08 | |
Dec. 9, 2015 | Insider | 1,000 | $14.69 | Buy | $14,690.00 | |
Dec. 7, 2015 | insider | 4,185 | $13.82 | Sell | $57,836.70 | |
Nov. 9, 2015 | insider | 4,185 | $16.26 | Sell | $68,048.10 | |
Oct. 5, 2015 | insider | 4,185 | $14.43 | Sell | $60,389.55 | |
Sept. 8, 2015 | insider | 4,185 | $19.58 | Sell | $81,942.30 | |
Sept. 8, 2015 | CEO | 60,000 | $19.86 | Sell | $1,191,600.00 | |
July 6, 2015 | Insider | 8,371 | $22.86 | Sell | $191,361.06 | |
July 6, 2015 | CEO | 60,000 | $23.22 | Sell | $1,393,200.00 | |
May 5, 2015 | Insider | 800 | $16.36 | Buy | $13,088.00 | |
Dec. 2, 2014 | Insider | 1,000 | $21.17 | Buy | $21,170.00 | |
Nov. 17, 2014 | EVP | 20,000 | $22.68 | Sell | $453,600.00 | |
Nov. 3, 2014 | EVP | 20,000 | $25.47 | Sell | $509,400.00 | |
Nov. 3, 2014 | CEO | 30,000 | $24.95 | Sell | $748,500.00 | |
Oct. 7, 2014 | EVP | 20,000 | $26.90 | Sell | $538,000.00 | |
Oct. 1, 2014 | CEO | 30,000 | $26.28 | Sell | $788,400.00 | |
Oct. 1, 2014 | Insider | 868 | $27.06 | Sell | $23,488.08 | |
Sept. 22, 2014 | EVP | 20,000 | $25.55 | Sell | $511,000.00 | |
Sept. 15, 2014 | Insider | 2,000 | $28.67 | Sell | $57,340.00 | |
Sept. 4, 2014 | Director | 4,000 | $35.14 | Sell | $140,560.00 | |
Aug. 26, 2014 | Major Shareholder | 200,000 | $35.14 | Sell | $7,028,000.00 | |
Aug. 25, 2014 | Major Shareholder | 366,666 | $33.98 | Sell | $12,459,310.68 | |
Aug. 18, 2014 | EVP | 10,830 | $36.07 | Sell | $390,638.10 | |
Aug. 15, 2014 | Major Shareholder | 4,061 | $36.54 | Sell | $148,388.94 | |
Aug. 4, 2014 | CFO | 30,000 | $29.74 | Sell | $892,200.00 | |
Aug. 4, 2014 | EVP | 20,000 | $29.42 | Sell | $588,400.00 | |
July 15, 2014 | Insider | 2,000 | $31.35 | Sell | $62,700.00 | |
July 7, 2014 | CFO | 30,000 | $32.74 | Sell | $982,200.00 | |
July 1, 2014 | CEO | 30,000 | $31.53 | Sell | $945,900.00 | |
June 23, 2014 | EVP | 20,000 | $28.42 | Sell | $568,400.00 | |
June 16, 2014 | Insider | 2,000 | $26.42 | Sell | $52,840.00 | |
June 16, 2014 | EVP | 25,012 | $26.38 | Sell | $659,816.56 | |
June 2, 2014 | CEO | 30,000 | $22.20 | Sell | $666,000.00 | |
May 19, 2014 | EVP | 5,000 | $22.28 | Sell | $111,400.00 | |
May 5, 2014 | CFO | 30,000 | $21.53 | Sell | $645,900.00 |
Insiders are both buying and selling Epizyme Inc stock.
The insider traders at Epizyme Inc are: Robert A Copeland, Andrew E Singer, Peter Tai-Ching Ho, Shefali Agarwal, Robert B Bazemore, David M Mott, Joseph Beaulieu, Robert Copeland, Robert J Gould, Robert A. Copeland, Matthew Ros, Eric Hedrick, Jason Rhodes, Paolo Tombesi, Robert B. Bazemore, Robert Gould, Robert J. Gould, Jason P Rhodes, Jeffery Kutok, Carl Goldfischer, Bay City Capital Llc, Venture Fund I L.P. Astellas, Andrew E. Singer, Bay City Capital Fund V Co-Inv, Celgene European Investment Co, M James Barrett, Pablo G Legorreta, Ryan D Drant, and Stephen Garbacz
The most active insider trader at Epizyme Inc is Robert A Copeland with 14 trades.
Bay City Capital Llc has sold the most Epizyme Inc stock with a total value of $26,515,310.68.
Pablo G Legorreta has bought the most Epizyme Inc stock with a total value of $68,000,001.00.
The most recent insider trade for Epizyme Inc was on April 11, 2022.
The single biggest insider buy for Epizyme Inc was from Pablo G Legorreta with a total value of $34,000,000.50 on Jan. 31, 2022.
The single biggest insider sell for Epizyme Inc was from Bay City Capital Llc with a total value of $12,459,310.68 on Aug. 25, 2014.